Skip to main content
. 2017 Jul 10;7(7):e016300. doi: 10.1136/bmjopen-2017-016300

Table 2.

Characteristics of macrolide resistance in Mycoplasma genitalium specimens by gender (Alberta STI clinics, January to April 2016, n=92)

Category Macrolide resistance Grand total
Female Male
Resistance (n=22) Susceptible (n=23) Total (n=45) p Value Resistance (n=30) Susceptible (n=17) Total (n=47) p Value
Median age (IQR) 22 (20–26) 26 (22–29) 24 (20–28) 0.04 29 (23–41) 27 (25–40) 28 (24–41) 0.90 26 (22–31)
Ethnicity
Caucasian 10 (45.5) 12 (54.5) 22 (50.0) 0.83 22 (75.9) 14 (87.5) 36 (80.0) 0.80 58 (65.2)
Indigenous 6 (27.3) 5 (22.7) 11 (25.0) 1 (3.4) 0 1 (2.2) 12 (13.5)
Other 6 (27.3) 5 (22.7) 11 (25.0) 6 (20.7) 2 (12.5) 8 (17.8) 19 (21.3)
Sexual partners
Heterosexual 14 (48.3) 13 (81.3) 27 (60.0) 0.06
Same sex 15 (51.7) 3 (18.8) 18 (40.0)
Testing location
Calgary 5 (22.7) 8 (34.8) 13 (28.9) 0.37 10 (33.3) 9 (52.9) 19 (40.4) 0.19 32 (34.8)
Edmonton 17 (77.3) 15 (65.2) 32 (71.1) 20 (66.7) 8 (47.1) 28 (59.6) 60 (65.2)
Symptomatic
No 15 (68.2) 14 (63.6) 29 (65.9) 0.75 15 (51.7) 11 (68.8) 26 (57.8) 0.27 55 (61.8)
Yes 7 (31.8) 8 (36.4) 15 (34.1) 14 (48.3) 5 (31.3) 19 (42.2) 34 (38.2)
HIV status
Negative 19 (95.0) 16 (80.0) 35 (87.5) 0.34 20 (71.4) 8 (50.0) 28 (63.6) 0.11 63 (75.0)
Positive 0 0 0 2 (7.1) 0 2 (4.5) 2 (2.4)
Unknown 1 (5.0) 4 (20.0) 5 (12.5) 6 (21.4) 8 (50.0) 14 (31.8) 19 (22.6)
Coinfections
Chlamydia 3 (13.6) 7 (30.4) 10 (22.2) 0.28 3 (10.0) 2 (11.8) 5 (10.6) 1.00 15 (16.3)
Gonorrhoea 2 (9.1) 2 (8.7) 4 (8.9) 1.00 2 (6.7) 0 2 (4.3) 0.53 6 (6.5)
MPC/NGU 0 0 0 6 (20.0) 3 (17.6) 9 (19.1) 1.00

Missing data: ethnicity (female=1, male=2), symptomatic (female=1, male=2), HIV status (female=5, male=3), sexual partners=2.

MPC, mucopurulent cervicitis; NGU, non-gonococcal urethritis.